I bought in at 0.793 - news FDA before or at last nov. 3
Recent ICU News
- SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026 • GlobeNewswire Inc. • 03/30/2026 12:20:00 PM
- SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/25/2026 08:05:00 PM
- SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 • GlobeNewswire Inc. • 03/18/2026 08:05:00 PM
- Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 03/13/2026 12:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th • GlobeNewswire Inc. • 03/10/2026 02:21:44 PM
- SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI • GlobeNewswire Inc. • 03/05/2026 01:20:00 PM
- SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) • GlobeNewswire Inc. • 02/09/2026 01:20:00 PM
- SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference • GlobeNewswire Inc. • 01/29/2026 01:25:00 PM
- SeaStar Medical Announces 2026 Milestones • GlobeNewswire Inc. • 01/07/2026 01:13:00 PM
- SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference • GlobeNewswire Inc. • 01/06/2026 01:53:00 PM
- SeaStar Medical Announces 1-for-10 Reverse Split • GlobeNewswire Inc. • 12/23/2025 09:25:00 PM
- SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference • GlobeNewswire Inc. • 11/20/2025 02:52:00 PM
- SeaStar Medical Announces Appointment of Michael Messinger as CFO • GlobeNewswire Inc. • 11/17/2025 01:43:00 PM
- SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/13/2025 09:05:00 PM
- SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025 • GlobeNewswire Inc. • 11/05/2025 03:03:00 PM
- SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children • GlobeNewswire Inc. • 09/29/2025 12:36:00 PM
- SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury • GlobeNewswire Inc. • 09/24/2025 08:22:00 PM
- SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children • GlobeNewswire Inc. • 09/23/2025 12:23:00 PM
- SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2025 10:13:42 PM
- SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival • GlobeNewswire Inc. • 09/02/2025 12:22:00 PM
- SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/13/2025 08:05:00 PM
- SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025 • GlobeNewswire Inc. • 08/07/2025 02:00:00 PM
- SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI) • GlobeNewswire Inc. • 08/06/2025 12:33:00 PM
- SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 07/31/2025 07:01:12 PM
- SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients • GlobeNewswire Inc. • 07/22/2025 12:20:00 PM
